New Clinical Trials: March 2024

The below are the clinical trials posted for the first time in March 2024.

Phase 4:

1. Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
2. Anesthesia and Non-small Cell Lung Cancer Recurrence
3. Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
4. Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
5. Rivaroxaban Sotorasib Interaction Study
6. Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Low-Risk Polycythemia Vera
7. Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery
8. Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block
9. Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance

Phase 3:

1. Tobacco Education and Lung Health Study (TEAL)
2. A Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
3. A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
4. A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
5. Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
6. A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
7. Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced But Resecable Colon Cancer in the Elderly of 70 Years Old or More
8. Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
9. A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer
10. DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
11. Optimising Patient Experience in Head and Neck Radiotherapy
12. A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
13. tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
14. CardioPROTECTion With Dapagliflozin in Breast Cancer Patients Treated With AnthrAcycline - PROTECTAA TRIAL
15. A Study to Compare ABP 234 and KeytrudaΒ® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
16. A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
17. A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
18. A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial
19. Metronomic Capecitabine in Stage III Gastric Cancer
20. Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
21. Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
22. Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies
23. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
24. Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-grade Glioma
25. D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
26. MK-2870 Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) and Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
27. A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
28. Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors
29. A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
30. A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
31. A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
32. A Study to Assess Efficacy and Safety of Pembrolizumab With or Without MK- 2870 in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
33. HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
34. Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
35. A Phase β…Ά Study of Hemay022 in Combination With AI In Advanced Breast Cancer
36. Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Phase 2-3:

1. BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
2. Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation
3. Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
4. Topical Tacrolimus for Breast Cancer-related Lymphedema
5. A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled Study
6. INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
7. Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
8. A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients
9. VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
10. A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)
11. Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Phase 2:

1. Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
2. Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
3. Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
4. GIST Oral Paclitaxel(Liporaxel)
5. Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
6. Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
7. A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
8. Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
9. REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis
10. Hypofractionated Radiochemotherapy
11. The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
12. Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
13. High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases
14. Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
15. A Phase II Multicenter Clinical Study of Improved Short-course Radiotherapy Combined With CAPOX and PD-1 Monoclonal Antibody for Locally Advanced Mid-low Rectal Cancer
16. Neoadjuvant SBRT in Localized Advanced HNSCC
17. 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
18. Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
19. Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
20. Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
21. A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
22. Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis
23. Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
24. HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
25. Maitake for Integrative Cancer Care
26. Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
27. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
28. A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
29. Nodular Shrinking in Dupuytren Disease
30. Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
31. A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)
32. FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
33. Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
34. Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
35. Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
36. Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
37. A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
38. A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
39. Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC
40. Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
41. Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
42. Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
43. Serplulimab Combined With CCRT for LS-SCLC.
44. Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure
45. SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
46. Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
47. Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
48. 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma
49. The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
50. Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
51. A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
52. TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma
53. Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)
54. Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
55. Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
56. Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
57. Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
58. Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
59. A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
60. Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
61. ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
62. Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
63. Ma-Spore ALL 2020 Study
64. Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
65. A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer
66. Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
67. Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma
68. A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
69. A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXD) In Subjects With Recurrent Or Metastatic Solid Tumors
70. Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
71. A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
72. HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
73. Toripalimab Combined With SBRT for NSCLC
74. 177Lu-DOTATATE for Recurrent Meningioma
75. Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
76. Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)
77. TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer
78. Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions
79. RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3
80. Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
81. Dynamic Changes in Circulating Tumour Cells Protein Expression
82. Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
83. A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
84. A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)
85. Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
86. Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
87. A Study of Pasireotide in People With Prolactinoma
88. Anti-Lag-3 (Relatlinib) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
89. Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
90. Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
91. Heavy Strength Training in Head and Neck Cancer Survivors
92. The IMPACT Implementation-Effectiveness Trial
93. A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
94. Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations
95. Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery
96. Myeloprotection With Trilaciclib in Pan-cancer Population
97. A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
98. Pemigatinib for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma or Marginal Zone Lymphoma
99. Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
100. Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
101. Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure
102. Phase II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
103. iTAPVR Study - Phase II Randomized Study
104. Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
105. Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI
106. Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
107. Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
108. Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
109. Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
110. Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
111. Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma
112. Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
113. A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
114. Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
115. Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study
116. An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC
117. Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
118. First-line Regimen With QL1706 Plus Chemo Β± Bev in PDAC Patients
119. A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
120. A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
121. Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy
122. Phase 2 Study of WGI-0301 in Combination With Sorafenib for Advanced HCC
123. Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
124. A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
125. Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
126. Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
127. A Phase II Study of Surufatinib Combined With PD-L1 and mFOLFOX6 as Second-line Treatment for Advanced PRAD
128. Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
129. Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis
130. Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
131. Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab
132. Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Phase 1-2:

1. A Study for HSK39775 in Participants With Solid Tumors
2. Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
3. PTCy and ATG for MSD and MUD Transplants
4. Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
5. Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL
6. Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Acute Lymphoblastic Leukemia/Lymphoma
7. Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
8. A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
9. Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
10. TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
11. A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
12. 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer
13. A Phase I/II Clinical Study to Evaluate The Safety, PK, PD of GH55 in Patients With MAPK Mutant Advanced Solid Tumors
14. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib in Combination With Trastuzumab Deruxtecan or With Trastuzumab Emtansine and to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
15. Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
16. A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors
17. Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
18. A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
19. A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
20. FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
21. Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
22. Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
23. Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
24. Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
25. Study of 23ME-01473 in Patients With Advanced Solid Malignancies
26. HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
27. Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
28. 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
29. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
30. Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.
31. Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
32. CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia
33. Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
34. A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
35. Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
36. Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
37. Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma

Phase 1:

1. Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
2. Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
3. Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
4. CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
5. Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer
6. A Study of BRY805 in Participants With Advanced Solid Tumors
7. A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
8. A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
9. Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
10. A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers
11. Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
12. 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
13. SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
14. A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
15. PAS-004 in Patients With Advanced Solid Tumors
16. NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
17. Study of STP938 in Advanced Solid Tumours
18. Intratumoral CAN2109 in Subjects With Solid Tumors or Lymphomas
19. PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL
20. Trial of INI-4001 in Patients With Advanced Solid Tumours
21. M1774 Human Mass Balance Study (DDRIVER Solid Tumors 303)
22. A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
23. A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
24. A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
25. FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
26. A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
27. A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
28. Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
29. Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
30. LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
31. Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
32. A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
33. A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
34. Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
35. Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
36. A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
37. Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
38. Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
39. Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)
40. Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical Trial
41. ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
42. Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors
43. A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma
44. A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
45. A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
46. Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
47. Safety and Efficacy of NRT6003 in Patients With Unresectable Hepatocellular Carcinoma
48. Assessing the Efficacy of Repeat, Monthly Treatments of Cutaneous Neurofibromas (cNFs)
49. Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
50. Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care
51. Avapritinib With Decitabine in Patients With SM-AHN
52. A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
53. TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
54. Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications
55. Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
56. Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)
57. Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy
58. Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
59. Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain
60. A Study of HC006 in Subjects With Advanced Solid Tumors
61. TIL for Patients With Advanced Solid Tumor
62. ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors
63. Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
64. A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
65. SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
66. A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL
67. A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
68. Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and KeytrudaΒ® in Patients With Malignant Neoplasms
69. A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
70. TGRX-326 Pharmacokinetic Drug Interaction
71. A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
72. Ivosidenib and Ruxolitinib in Patients With Advanced Blood Cancers That Have IDH1 Gene MutationPhase MPNs
73. CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
74. A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
75. Study of REM-422 in Patients With AML or Higher Risk MDS
76. A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors
77. A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
78. Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
79. Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
80. A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
81. Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
82. Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
83. Revumenib in Combination With 7+3 + Midostaurin in AML
84. A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
85. A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
86. HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
87. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
88. AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)
89. Early Phase 1:

1. Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
2. 177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer
3. Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
4. To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
5. Using Chronobiology to Improve Lenvatinib Efficacy
6. Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
7. DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
8. Early Nutrition Intervention for M1 Stage Cancer Patients
9. Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
10. An Exploratory Study by Fast CAR T Cells
11. A Phase 0 Pilot Study of Memory-like Natural Killer (NK) Cell Immune Therapy in Combination With N-803 in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
12. Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
13. The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
14. Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
15. Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Phase Not Applicable:

1. Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment
2. Evaluating Changes in Quality of Life After Near Margin-less Adaptive Radiation Therapy Compared to Standard Stereotactic Ablative Body Radiotherapy in Localized Prostate Cancer
3. Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis
4. Digestive Tract Cancer and CIPN
5. Interest of Light Therapy in Hematology - The PHOTO-TREAT Study
6. Technological Gaming in Cancer Survivors (WINNERS)
7. VR for Surgical Prehabilitation and Rehabilitation
8. Leveraging Telehealth to Improve Oral Health Among Cancer Survivors
9. Neoadjuvant Radiotherapy for Breast Cancer
10. Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
11. Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma
12. Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.
13. Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer
14. DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
15. Effect of Oral Enteral Nutrition in Nasopharyngeal Carcinoma Survivors With Swallowing Disorders
16. Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
17. Laser Ablation in the Treatment of High-grade Cervical Lesions
18. Low and Intermediate Risk oliGometastatic coloREctal cancEr patieNts Treated With Stereotactic ABlative Radiotherapy
19. mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer Objectives
20. CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
21. Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries
22. MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
23. Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
24. Outcomes and Cosmesis With Whole Breast Irradiation and Boost
25. The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale
26. Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
27. Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
28. Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
29. RealMove (Lung): Assessing Tumour Motion With Dynamic MRI
30. TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
31. Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction
32. Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
33. Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
34. Percent Weight Change in the Medical Supplement Group of Early Breast Cancer
35. Application of Cognitive Training Based on Remind Strategy in Glioma Patients With Cognitive Impairment
36. Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
37. MRD Response-adapted Allo-HSCT for Adverse-risk AML
38. Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
39. Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer
40. Testing the Engaged Approach to Lung Cancer Screening
41. Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps
42. A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB
43. Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer
44. Developing the Precision Nursing Education Program to Young Colorectal Cancer Survivors
45. Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
46. Remote Assessment and Intervention for Behavior Problems in Kids With TSC
47. Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
48. Open Versus Laparoscopic Ablation of Liver Malignancies
49. Effects of HICT and Intermittent Fasting on PCOS
50. Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
51. fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
52. Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
53. Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
54. Opportunistic Gastric Cancer Screening
55. A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)
56. Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
57. Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
58. Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents
59. Effects of Education After Colorectal Cancer Screening
60. Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
61. Testicular Self-Examination Awareness in Young Men
62. Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease
63. PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments
64. Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment
65. Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport
66. FCI in Post-operative Low Grade Gliomas
67. Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
68. Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy
69. Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling
70. Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors
71. End to End Versus Side to End Anastomosis After Anterior Resection of Cancer Rectum
72. Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
73. mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public
74. Virtual Reality to Promote Relaxation Prior to Simulation
75. A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
76. Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue
77. A Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Cancer (RALI)
78. Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial
79. Role of Tumoral Biomarker B3 Adrenergic Receptor in Paediatric Solid Tumours
80. Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador
81. Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial
82. Feasibility of Targeted Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Patients Suspicious of Early-stage Lung Cancer
83. Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
84. The Effect of Breathing Exercise on Sleep and Stress Levels in Women With Breast Cancer Receiving Chemotherapy Treatment
85. Online Proton Adaptive Radiotherapy
86. Community Services Navigation to Advance Health Equity in Breast Cancer Screening
87. Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
88. Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
89. MRI Guided Prostate Biopsy
90. Feasibility Testing a Decision-support Intervention for Clinical Trials
91. The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
92. The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery
93. Comprehensive Connected Cancer Care (C4): Intervention Evaluation
94. Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
95. Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors
96. Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy
97. TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy
98. Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients
99. A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer
100. Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study
101. Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
102. The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease
103. A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
104. Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
105. Lung Cancer Screening by Artificial Intelligence Device
106. Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
107. Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
108. Exercise and Health Counseling in Pediatric Hematopoietic Stem Cell Transplantation
109. High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
110. Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their Spouses
111. Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer Survivors
112. Brain Metastasis Development Mechanism in BCBM Patients
113. CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
114. "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
115. Epigenomic and Machine Learning Models to Predict Pancreatic Cancer
116. Stellate Ganglion Block for Preserving Arteriovenous Fistula in Hemodialysis Patients Undergoing Major Lower Limb Orthopedic Surgery
117. Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt
118. Pulsed Electromagnetic Fields for Analgesia Post Mastectomy
119. The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
120. Adjuvant Hypofractionated Radiotherapy for Prostate Cancer
121. Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
122. PediCARE Health Equity Intervention in High-Risk Neuroblastoma
123. Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
124. Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service
125. Evaluation of Mobiderm Intimate Bra in the Management of Breast Edema Related to Breast Cancer Treatment
126. A Mobile Application to Improve Postoperative Outcomes in Colorectal Cancer
127. Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma
128. Quality of Life Assessment for Early Identification of Supportive Care Needs in Oncology Patients
129. Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1
130. Needs Navigation for Caregivers of AYAs
131. Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules
132. Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
133. Development of a Neuronal Microscope
134. PET Imaging of 68Ga-Her2-affibody in Tumors With High Her2 Expression
135. A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome
136. POZIKIDS: Exercise and Comprehensive Care to Improve the Quality of Life of Children and Adolescents With Cancer
137. The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
138. INvestigating the Value of Early Sleep Therapy
139. Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome
140. A Clinical Investigation to Evaluate Microwave Imaging Via MammoWaveΒ® in a Population-based Screening Program for Early Breast Cancer Detection
141. An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
142. Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas
143. VIDeOS for Smoking Cessation
144. Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
145. Pancreatic Cancer Screening in a Population at High Risk
146. Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
147. A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
148. Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
149. A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
150. Correlating Improvement in PCOS Symptoms to the Percentage of Body Weight Lost in Females Also Living With Obesity
151. Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
152. Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
153. Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma
154. Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
155. The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)
156. Reach Through Equitable Implementation of Turtle Island Tales
157. Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
158. Exercise for Improving Radiotherapy Efficacy in Rectal Cancer
159. Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy
160. Exercise and Diet Interventions During Immunotherapy in Melanoma Patients
161. A Biobehavioral Intervention for Latino/Hispanic Young Adults With Cancer
162. De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)
163. Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism
164. Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
165. ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening
166. PCOS Immune Function Predicts Metformin Efficacy
167. Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
168. Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
169. Improving Social Cognition and Social Behaviour in Various Brain Disorders
170. Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy
171. Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer
172. PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
173. Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
174. Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
175. Effects of Flavor Modification for Management of Radiation Induced Dysgeusia
176. Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
177. Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer With Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial
178. Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan
179. Single Arm Pilot Trial of Virtual and In-person STEP2
180. Exercise Intervention for Patients With Cancer Cachexia: Effects of a 12-week Program and One-year Follow-up.
181. Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov